• Explore /
  • Poster
  • / Primary analysis of TROPHY-U-01 cohort 3, a phase 2 study of sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) that progressed after platinum (PT)-based therapy.

Primary analysis of TROPHY-U-01 cohort 3, a phase 2 study of sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) that progressed after platinum (PT)-based therapy.

Abstract Video & Slides Poster

Authors

null

Petros Grivas

University of Washington; Fred Hutchinson Cancer Center, Seattle, WA

Petros Grivas , Damien Pouessel , Chandler H. Park , Philippe Barthelemy , Manojkumar Bupathi , Daniel P. Petrylak , Neeraj Agarwal , Sumati Gupta , Aude Flechon , Chethan Ramamurthy , Nancy B. Davis , Alejandro Recio-Boiles , Cora N. Sternberg , Astha Bhatia , Cabilia Pichardo , Mitch Sierecki , Julia Tonelli , Huafeng Zhou , Scott T. Tagawa , Yohann Loriot

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03547973

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 518)

DOI

10.1200/JCO.2023.41.6_suppl.518

Abstract #

518

Poster Bd #

L2

Abstract Disclosures

Similar Posters

First Author: Scott T. Tagawa

First Author: Jyoti D. Patel

First Author: Ignace Vergote

First Author: Sami Diab